Skip to main content
Clinical Trials/CTRI/2021/08/036014
CTRI/2021/08/036014
Not yet recruiting
Phase 2

Comparative clinical study to asses efficacy of bharangikanadi kashay and uroh pradeshi lavantakta taila snehana swedana in the management of tamaka shwasa w.r.t bronchial asthma

DrJayanti Dutta0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
DrJayanti Dutta
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
DrJayanti Dutta

Eligibility Criteria

Inclusion Criteria

  • 1\. Duration not more than 2years
  • 2\. History of intermittent or persistent asthma symptoms. FEV1 between 50% to 85% of predicted value.
  • 3\. Non\-smoker/left smoking past 3 months.
  • 4\.Pre bronchodilator FEVI1 values in range of 60\-80%
  • 5\. Normal SGPT and serum creatinine

Exclusion Criteria

  • 2\. Active upper respiratory tract infection within 3 weeks
  • 3\. Acute sinus disease requiring antibiotic treatment within 1 week therapy, inhaled
  • 4\. Medications: Warfarin, anti\-platelet
  • or parental corticosteroid within 1
  • 5\. Patient receiving immunotherapy 6 months before pre\-study visit
  • 6\. Pregnant females, patients suffering from concurrent systemic disease like cardiopulmonary, diarrheal
  • T.B., bronchiectasis, CHF, hepatic dysfunction, neurological disorders, and disorders or having hemoglobin less than 10 g/dl
  • 7\. Patient having complications like CCF, Cor\-pulmonale, Emphysema, Pneumonia,

Outcomes

Primary Outcomes

Not specified

Similar Trials